• No se han encontrado resultados

MicroRNAs: Clinical Relevance in Colorectal Cancer

N/A
N/A
Protected

Academic year: 2021

Share "MicroRNAs: Clinical Relevance in Colorectal Cancer"

Copied!
14
0
0

Texto completo

Loading

Referencias

Documento similar

a) To systematically review the indicators of PPF in breast cancer. i) To study the associations between the main constructs from positive psychology and breast cancer. ii)

For the development of those therapeutic actions, multifunctional protein nanoparticles appear as one of the most promising gene therapy vectors due to their

We tested, by RT-PCR, the expression levels of TWIST1 in normal and tumor paired-sample tissues from a series of 151 colorectal cancer patients, in order to investigate its

Moreover, since the treatment with the BRAFi Vemurafenib also enhances autophagy in melanoma [40,41], colorectal cancer [47] and thyroid cancer cells [46], our results further

Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies. PIK3CA mutations in colorectal cancer

This review gives hand on recent advances of personalized oncology in several cancer disease models including leukemia, melanoma, breast cancer, lung cancer, colorectal cancer,

Dietary fiber in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study... luminal short

Aims: This study carried in patients with metastatic colorectal cancer (mCRC) or head and neck cancer (HNC) aims to evaluate, in a real-life setting, the relationship